Latest News and Press Releases
Want to stay updated on the latest news?
-
ADELAIDE, South Australia, March 13, 2014 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) has been named as the Innovative Asian Biotech of the Year at this week's BioPharma Asia Industry Awards...
-
NEW YORK and MELBOURNE, Australia, March 10, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that Jonathan R. Symonds, CBE, the former...
-
ADELAIDE, South Australia, March 10, 2014 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) (ADR:BMICY) CEO and managing director Dr Deborah Rathjen will present a company update at the renowned 26th...
-
NEW YORK and MELBOURNE, Australia, March 5, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that William M. Burns, former Chief...
-
CHICAGO, March 3, 2014 (GLOBE NEWSWIRE) -- DTZ, a leading global property services firm, has announced the appointment of Adam Stanley as Global Chief information Officer (CIO), effective March 3. Mr....
-
DENVER, Feb. 28, 2014 (GLOBE NEWSWIRE) -- Janus Capital Group Inc. (NYSE:JNS) today announced the launch of the Janus Multi-Sector Income Fund that seeks to identify compelling income-generating...
-
Highlights: The Alberta Energy Regulator announced today that it has granted approval of Coalspur's Vista project The AER approval is a significant milestone in the regulatory process for...
-
NEW YORK and MELBOURNE, Australia, Feb. 25, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today provided its 2014 half-year financial results and...
-
REVA to Hold Briefing Call on Financial Results for 2013 and Present at Cowen Health Care Conference
SAN DIEGO, Feb. 23, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's financial results through December 31, 2013,...
-
SAN DIEGO, Feb. 23, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that Dr. Alexandre Abizaid, co-principal investigator for REVA's RESTORE II...